Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

▤ Summary

Nuwellis received a $3 million NIH grant through its partner Koronis Biomedical Technologies to accelerate development of its pediatric Vivian CRRT system. The company plans to use the funding for software and firmware work, an initial investigational device study, and preparation for regulatory clearance. Vivian targets infants and children under 20 kilograms and aims to address a treatment gap in pediatric fluid management. Nuwellis says the new platform also strengthens its broader technology portfolio and supports future commercialization.

▦ Linked Companies